SATURDAY (8/31): World of Cardiology, Paris (5 days). Correvio Pharma(NASDAQ:CORV): Data from SPECTRUM study of Brinavess for atrial fibrillation. Resverlogix (OTCPK:RVXCF): Apabetalone data.  I have highlighed Apabetalone data,  Do we know if any trial data will be disclosed??   I wonder if we are in that 2 weel database lock by now,    That Third eye extion does expire Sept 16 so I would imagine TLD should be released prior to Sept 16, Could Aug 31 be a release date???